(Q38047583)

27 August 2017

title

Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? (English)

1 reference

27 August 2017

1 reference

Andres M Kanner

1

1 reference

27 August 2017

publication date

28 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

11

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

1093-1102

1 reference

An incident case-referent study of epileptic seizures in adults

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Major depression is a risk factor for seizures in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Depression and suicide attempt as risk factors for incident unprovoked seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Predictors of pharmacoresistant epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Psychiatric outcome after temporal lobectomy: a predictive study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Mood disorders and medical illness: a major public health problem

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Neurobiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Early postnatal stress confers enduring vulnerability to limbic epileptogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Anxiolytic effects of rapid amygdala kindling, and the influence of early life experience in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Effect of neonatal isolation on outcome following neonatal seizures in rats--the role of corticosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Gonadal, adrenal, and neuroactive steroids' role in ictal activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Low glial numbers in the amygdala in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Implications of decreased hippocampal neurogenesis in chronic temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Hippocampal atrophy in recurrent major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Untreated Depression and Hippocampal Volume Loss

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Hippocampal volume reduction in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Glial reduction in the subgenual prefrontal cortex in mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Glial cell abnormalities in major psychiatric disorders: the evidence and implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Antiepileptic drug response in temporal lobe epilepsy: A clinical and MRI morphometry study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Depression in epilepsy: a complex relation with unexpected consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Noradrenergic abnormalities in the genetically epilepsy-prone rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The role of glutamate on the action of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Increased cerebrospinal fluid glutamine levels in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Beyond monoamines: glutamatergic function in mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Increased levels of glutamate in brains from patients with mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Increased cortical GABA concentrations in depressed patients receiving ECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Corticocortical inhibition in human motor cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Evidence for impaired cortical inhibition in patients with unipolar major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Evidence of cortical inhibitory deficits in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Major depression and activation of the inflammatory response system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The role of cytokines in the pathophysiology of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The IL-1beta system in epilepsy-associated malformations of cortical development.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Cytokine effects on glutamate uptake by human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The serotonin axis: Shared mechanisms in seizures, depression, and SUDEP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Serotonin and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Preclinical antiepileptic actions of selective serotonin reuptake inhibitors--implications for clinical trial design

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Effects of several centrally active drugs on the sleep-wakefulness cycle of cats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Anticonvulsant effect of fluoxetine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Citalopram as treatment of depression in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

Biological antagonism and epileptic psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970201-6

7 January 2021

10.1016/S1474-4422(12)70201-6

Identifiers

DOI

1 reference

27 August 2017

1 reference